Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-004114
Date:2020-03-23
Issuer: BLUEPRINT MEDICINES CORP (BPMC)
Original Submission Date:

Reporting Person:

ALBERS JEFFREY W.
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-03-23 M 20,000 a $1.87 141,434 direct
COMMON STOCK 2020-03-23 M 80 a $1.87 141,514 direct
COMMON STOCK 2020-03-23 M 19,920 a $8.80 161,434 direct
COMMON STOCK 2020-03-23 S 484 d $55.34 160,950 direct
COMMON STOCK 2020-03-23 S 3,293 d $54.62 157,657 direct
COMMON STOCK 2020-03-23 S 1,936 d $53.54 155,721 direct
COMMON STOCK 2020-03-23 S 2,100 d $52.11 153,621 direct
COMMON STOCK 2020-03-23 S 8,850 d $51.30 144,771 direct
COMMON STOCK 2020-03-23 S 3,337 d $50.40 141,434 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 1.87 2020-03-23 deemed execution date M 20,000 (d) 2024-07-30 common stock 20,000 $1.87 173,903 direct
STOCK OPTION (RIGHT TO BUY) 1.87 2020-03-23 deemed execution date M 80 (d) 2024-07-30 common stock 80 $1.87 0 direct
STOCK OPTION (RIGHT TO BUY) 8.8 2020-03-23 deemed execution date M 19,920 (d) 2025-02-10 common stock 19,920 $8.80 87,170 direct
Footnotes
IDfootnote
f1 effected pursuant to a trading plan adopted on december 11, 2018 pursuant to rule 10b5-1 under the securities exchange act of 1934, as amended.
f2 the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $55.25 to $55.43 per share. the reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (7) to this form 4.
f3 the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $54.15 to $55.04 per share.
f4 the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $53.06 to $53.93 per share.
f5 the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $51.84 to $52.805 per share.
f6 the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $50.84 to $51.82 per share.
f7 the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $49.83 to $50.74 per share.
f8 this option was granted on july 30, 2014 and is fully vested.
f9 this option was granted on february 10, 2015 and is fully vested.
WhaleWisdom Logo

Elevate your investments